In mice genetically more susceptible to PTSD following a stressful event, researchers found an increased expression of cortisol receptors on neurons in the CA1 region of the dorsal hippocampus. Those increased receptors enabled an elevated expression of the HCN1 protein and TRIP8b, reducing neural excitability.
Fatigue and headaches top the list of common lingering symptoms four months after COVID infection, with muscle aches, changes in sense of taste and smell, cough, and congestion following close behind.
Translumbosacaral neuromodulation therapy (TNT), a magnetic stimulation technology commonly used for neuropathy, can improve fecal incontinence in the short term.
MicroRNAs that should attack SARS-CoV-2, the virus that causes COVID-19, diminish with age, and due to chronic health problems. The findings shed light on why those who are older, and those with health conditions are more susceptible to coronavirus.
A new mathematical model reveals a more realistic picture of the number of likely COVID-19 cases, both in the US and worldwide, compared to reported data.
Neuroimaging technology has limited applicability when assessing a defendant's sanity, a new study reports.
People who suffer from severe insomnia often report having suicidal thoughts. A new study reveals prescribing controlled sleeping medications can help to reduce depression and suicidality in those with chronic sleep problems.